All In Biotech

Drug Trial Radar · NCT01243424

CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes

A Multicentre, International, Randomised, Parallel Group, Double Blind Study to Evaluate Cardiovascular Safety of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.

Last checked: Nov 19, 2026Latest source record: Jan 7, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 6,103 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

6,103

Actual

Start

Nov 11, 2010

Primary completion

Aug 21, 2018

Study completion Aug 21, 2018

Sponsor

Lead sponsor
Boehringer IngelheimBoehringer Ingelheim
Sponsor type
Industry
Collaborators
Eli Lilly and Company
First posted
Nov 18, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 40 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The aim of the study is to investigate the longterm impact on cardiovascular morbidity and mortality, relevant efficacy parameters (e.g., glycaemic parameters) and safety (e.g., weight and hypoglycaemia) of treatment with linagliptin in patients with type 2 diabetes at elevated cardiovascular risk receiving usual care, and compare outcome against glimepiride.

Conditions

  • Diabetes Mellitus, Type 2

Interventions

  • linagliptinDrug

    linagliptin tablets 5mg QD

  • glimepirideDrug

    glimepiride over-encapsulated tablet 1-4 mg QD

  • linagliptin placeboDrug

    linagliptin placebo

  • glimepiride placeboDrug

    glimepiride placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The First 3-point Major Adverse Cardiovascular Events (3P-MACE)Time frame: From randomization until individual day of trial completion, up to 432 weeks

Locations

613 sites in 43 countries. Site status is shown where the registry gives one.

  • North Alabama Research Center, LLC

    Athens, Alabama

  • Alabama Internal Medicine, PC

    Birmingham, Alabama

  • Cahaba Research, Inc.

    Birmingham, Alabama

  • Internal Medicine Center, LLC

    Mobile, Alabama

  • Diagnostic and Medical Clinic

    Mobile, Alabama

  • Extended Arm Physicians, Inc.

    Montgomery, Alabama

  • Office of Dr. Terence T. Hart MD

    Tuscumbia, Alabama

  • Advanced Clinical Research

    Pell City, Alaska

  • Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC

    Mesa, Arizona

  • Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC

    Mesa, Arizona

  • Genova Clinical Research

    Tucson, Arizona

  • Quality of Life Medical & Research Center

    Tucson, Arizona

  • Northeast Arkansas Baptist Clinic

    Jonesboro, Arkansas

  • Medical Investigations, Inc

    Little Rock, Arkansas

  • Aureus Research, Inc

    Little Rock, Arkansas

  • Desert Oasis Healthcare

    Bermuda Dunes, California

  • Edinger Medical Group and Research Center

    Fountain Valley, California

  • Clinical Trials of St. Jude Heritage Med. Group

    Fullerton, California

  • Long Beach Center for Clinical Research

    Long Beach, California

  • Office of Dr. Richard S. Cherlin

    Los Gatos, California

  • Providence Clinical Research

    North Hollywood, California

  • Chaparral Medical Group, Inc

    Pomona, California

  • ARI Clinical Trials, Inc

    Redondo Beach, California

  • San Diego Sports Medicine and Family Health Center

    San Diego, California

  • West Coast Research, LLC

    San Ramon, California

  • University of California Los Angeles

    Sylmar, California

  • Metabolic Institute of America

    Tarzana, California

  • Matrix Research Institute

    Tustin, California

  • Orange County Research Center

    Tustin, California

  • Westlake Medical Research

    Westlake Village, California

  • Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC

    Colorado Springs, Colorado

  • Clinical Research Advantage, Inc./Rita B. Chuang, MD, LLC

    Colorado Springs, Colorado

  • East Coast Medical Associates

    Boca Raton, Florida

  • Todd Kazdan, DO Family Practice

    Davie, Florida

  • Century Clinical Research, Inc

    Daytona Beach, Florida

  • Doral Research Center

    Doral, Florida

  • Riverside Clinical Research

    Edgewater, Florida

  • Alan Graff, MD, PA

    Fort Lauderdale, Florida

  • M & O Clinical Research, LLC

    Fort Lauderdale, Florida

  • Eastern Research

    Hialeah, Florida

Showing 40 of 613 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.